Your molecule Our mission

Whether you’re a fast-growing biotech or large pharma company, you need a partner who can give you a competitive advantage. Cambrex has the necessary expertise and equipment to handle almost any need, but what separates us from other contract development and manufacturing organizations (CDMOs) is our approach. Our scientist-led teams love to be challenged, and they collaborate with you from the start to understand your program’s unique requirements and ensure a smooth, seamless journey from early development to commercialization.

Learn more about our services

Drug Substance

Working with a challenging API or complex process? Our development and manufacturing experts can help you get the science right as you scale.

Learn More

Drug Product

Regardless of your finished dosage form, we can help you advance your product seamlessly through early development and prepare you for scale-up.

Learn More

Analytical Services

Your molecule is unique, which is why we design customized, phase-appropriate analytical programs that maintain your momentum across the drug lifecycle.

Learn More

Expertise across the entire drug development lifecycle

Early Phase

Late Phase

Commercial

Generics

IND Enabling Services

Our streamlined IND data collection and submission strategy, based on our decades of experience, helps accelerate your filing process without sacrificing quality.

Analytical Testing

We offer comprehensive analytical testing services to provide the data you need for critical early-phase drug development decisions. At our state-of-the-art facilities, Cambrex experts ensure regulatory compliance and the highest standards for safety and efficacy.

Process Development

Our development experts specialize in using creative problem-solving to handle early-phase challenges while maintaining validation rigor to avoid late-stage process changes. This helps you advance more rapidly to late-stage manufacturing.

Clinical API Manufacturing

With decades of experience and broad capabilities, our flexible manufacturing and packaging solutions can support changing demands to meet your late-phase clinical trial needs.

Analytical Testing

By offering a comprehensive suite of analytical testing services, we can support your late-phase development and ensure your clinical trial materials meet the highest standards for safety and quality.

API Manufacturing

At Cambrex, our experts specialize in API manufacturing and scale-up from preclinical to commercial phases. We offer extensive manufacturing capabilities, streamlined technology transfer, and consistent support across all sites.

Technology Transfer

Although every technology transfer process is different, our experts apply their skills and knowledge to make the transition to commercial manufacturing as smooth as possible.

Generic API Manufacturing

Cambrex is a leading global supplier of generic APIs with sites in Italy, Sweden, and the US. We collaborate with generic drug firms before patent expiration and offer comprehensive services and manufacturing capabilities.

Intermediates and RSMs

Our global manufacturing facilities reliably supply high-quality advanced pharmaceutical intermediates and raw starting materials. We maintain a large catalog of APIs and have a proven track record for meeting cGMP standards.

1/4

Science, Powered by People

Science, Powered by People

Some CDMOs can be impersonal, cold, transactional. Cambrex is different because our people are different. We value innovation and teamwork, problem-solving and perseverance. We also firmly believe in the promise of medicine, and our experts hold themselves accountable as they collaborate with you to bring your molecule to life.

News

Cambrex Announces Strategic Agreement with Lilly to Support Biotech Collaborator Manufacturing

12.05.2024

Cambrex announces it has signed an agreement with Eli Lilly and Company (Lilly) to deliver accelerated access to clinical development capabilities for their biotech collaborators through Lilly Catalyze360-ExploR&D, Lilly’s early external innovation and collaboration arm.

View All News